Therefore, attempts have been made to combine or replace CA125 with other markers, and investigators have evaluated the ability of some established markers to improve the identification and prognosis of ovarian cancer [12], [17], [18], thus indicating that the addition of one or several markers to CA125 would improve diagnostic and prognostic performance if sensitivity was improved without a loss in specificity. This evidence concerns the gene MUC16 and ovarian cancer.